作者: Harish Patel , Shehriyar Mehershahi , Danial Haris Shaikh , Jasbir Makker , Sureshkumar Nayudu
DOI: 10.1002/CCR3.2501
关键词:
摘要: Thalidomide is often used for the management of refractory gastrointestinal angiodysplasia (GIAD). The tolerance, toxic profile, and compliance thalidomide are dose-dependent. low-dose (50 mg) safe a viable option bleeding related to GIAD.